Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04155801 · ClinicalTrials.gov registry record · NA
A Study to Assess the Efficacy and Safety of Salix Probiotic Blend in Participants With Functional Gastrointestinal Disturbances
A NA study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- NA
- Development phase
- 188
- Enrollment target
NCT04155801 is a NA study that has completed, run by Bausch Health Americas. The registered enrollment target is 188 participants.
The verdict
NCT04155801, a NA study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- NA
- Development phase
- 188 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the safety and efficacy of Salix Probiotic Blend, administered orally for 30 days, in participants with functional gastrointestinal (GI) disturbances.
Interventions
- DIETARY_SUPPLEMENT Salix Probiotic Blend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2019-10-11 |
| Est. Completion | 2020-02-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04155801
The ClinicalTrials.gov registry entry for NCT04155801 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 188 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Salix Probiotic Blend is the first listed.
NCT04155801 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04155801 about?
NCT04155801 is a clinical study titled "A Study to Assess the Efficacy and Safety of Salix Probiotic Blend in Participants With Functional Gastrointestinal Disturbances". The primary objective of this study is to assess the safety and efficacy of Salix Probiotic Blend, administered orally for 30 days, in participants with functional gastrointestinal (GI) disturbances.
What is the current status of trial NCT04155801?
This trial is currently completed. It is a NA study. The enrollment target is 188 participants. The study started on 2019-10-11. Estimated completion is 2020-02-14.
What interventions are being tested in trial NCT04155801?
The interventions under investigation include: Salix Probiotic Blend (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04155801?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.